Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
26.32
+0.06 (+0.23%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screaming Buys in March
March 04, 2024
These high-octane income stocks, which sport a scorching-hot average yield of 8.84%, can fatten the wallets of patient investors.
Via
The Motley Fool
Is Novavax a Buy Now?
March 04, 2024
The stock has dropped 98% over the past three years.
Via
The Motley Fool
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
March 04, 2024
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range.
Via
Investor's Business Daily
Plan Ahead! 7 Stocks to Buy Before Any Market Downturn Occurs
March 03, 2024
While red ink in the broader equities space could hurt most entities, these stocks to buy for a market downturn might be resilient.
Via
InvestorPlace
3 Volatility-Busting, Low-Beta Stocks to Grab Now
March 03, 2024
These are the undervalued low-beta stocks to buy as they represent blue-chip names with robust cash flow outlook.
Via
InvestorPlace
1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
March 03, 2024
Investors are so worried about a one-off situation that they're looking right past the bigger bullish picture.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Analyst Scoreboard: 9 Ratings For Pfizer
March 01, 2024
Via
Benzinga
This Is What Whales Are Betting On Pfizer
February 27, 2024
Via
Benzinga
Better Bull Market Buy: Novavax vs. Pfizer
February 22, 2024
Bull markets usually favor stocks with promising growth prospects.
Via
The Motley Fool
Hot on the Hedge Funds’ Trail: 3 Stocks Worth Your Bet?
March 02, 2024
With a 7.1% Q4 leap, hedge fund stocks underscore their role as incredible bets in a well-rounded portfolio.
Via
InvestorPlace
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
3 Overhyped Stocks Every Smart Investor Should Ignore
March 01, 2024
Learn why smart investors avoid overhyped stocks, highlighting three companies facing significant challenges in today's volatile market.
Via
InvestorPlace
Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds
February 29, 2024
Pfizer reports strong 77.8% efficacy for Abrysvo vaccine against RSV in adults 60+. Durable 88.9% efficacy after two seasons. Consistent protection for RSV A and B. No new adverse events. FY2023 sales...
Via
Benzinga
3 Starter Long-Term Stocks Every New Investor Should Own
February 28, 2024
These three long-term stocks for new investors provide a solid foundation, harmonizing risk with rewarding prospects for the long haul.
Via
InvestorPlace
3 Forgotten Dividend Stocks With a Yield of Over 5%
February 28, 2024
These are the undervalued dividend stocks to buy as they represent fundamentally strong companies poised for accelerated growth.
Via
InvestorPlace
7 Dividend Stocks to Buy to Secure Steady Income
February 28, 2024
Unlock financial growth with 7 standout dividend stocks in real estate, industrial, pharma, and telecom sectors for long-term success.
Via
InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
February 27, 2024
The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big.
Via
InvestorPlace
Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst
February 27, 2024
Income investors can enjoy the nearly 6% dividend yield even if growth doesn't return.
Via
The Motley Fool
7 Defensive Stocks to Weather Any Downturn With Ease
February 26, 2024
While circumstances may look favorable in the market, it doesn’t hurt for investors to consider defensive stocks – just in case.
Via
InvestorPlace
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
February 26, 2024
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare.
Via
InvestorPlace
3 Steal-of-a-Deal Stocks to Snap Up Right Now
February 26, 2024
Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now.
Via
InvestorPlace
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and...
Via
Benzinga
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
February 26, 2024
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher.
Via
Benzinga
7 Struggling Stocks to Sell Before Q2 2024
February 26, 2024
When you have stocks to sell, you also have an opportunity to reallocate that money into investments with a better growth window.
Via
InvestorPlace
Getting a Tax Refund? This Warren Buffett Stock Is a Great Way to Put It to Work
February 24, 2024
This Warren Buffett stock is a safe and proven capital appreciation vehicle.
Via
The Motley Fool
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil.
Via
InvestorPlace
3 No-Brainer Stocks to Buy Right Now for Less than $50
February 23, 2024
You won't have to shell out much cash to invest in these great stocks.
Via
The Motley Fool
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
7 Stocks to Buy for Bargain Hunters on the Prowl
February 22, 2024
Wager on these top bargain stocks poised for a comeback, offering both long-term gains and income, away from the growth stock bubble.
Via
InvestorPlace
Why Range-Bound Moderna Could Get A Boost On Its Fourth-Quarter Report
February 22, 2024
The company unexpectedly came in with fourth-quarter earnings that beat projections.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.